Abbas Shahmohammadi

Assistant Professor | M.D. University of Florida

  • Gainesville FL

Dr. Abbas Shahmohammadi specializes in pulmonary disease and critical care medicine.

Contact

University of Florida

View more experts managed by University of Florida

Biography

Dr. Abbas Shahmohammadi is the director of the UF Thoracic and Lung Transplant/ECMO Intensive Care Unit. He specializes in pulmonary disease and critical care medicine. His clinical interests are in acute respiratory distress syndrome (ARDS), extracorporeal membrane oxygenation (ECMO), lung transplantation and pulmonary arterial hypertension (PAH).

Areas of Expertise

Advanced Lung Failure
ARDS
COVID-19
ECMO/ECLS
Lung Transplantation

Media Appearances

250 days and counting: Waiting on new lungs after Covid

NBC News  online

2022-04-16

While most Americans are shedding their masks and returning to their pre-pandemic lives, Marie Jackson remains in a Chicago hospital room. She has been there for more than 250 days. There is no indication yet when Jackson, 53, will be able to go home. She's waiting on a new pair of lungs; hers were irreversibly scarred when she was sickened by Covid-19 last July.

View More

Active duty marine released from hospital after long battle with COVID-19

CBS 4 News  online

2021-11-17

After spending 5 months hospitalized at UF Health Shands Hospital, Robert Domen was able to walk out of the hospital. “I will live everyday forever grateful, thank-you," he said. Domen was greeted by Marines, family, friends and staff cheering him on, waving American flags, as he walked down the hall. Domen is an active duty Marine, who’s served for more than 30 years, and he attributes his triumphant battle with COVID to everything he learned in the military.

View More

Devine Intervention: Stars Align for Pulmonologist’s Lung Transplant

UF Health  online

2021-09-23

After night shifts in the ICU, Sean Devine is tired. This is not atypical. In fact, Sean and his family have grown to expect it. When he is on nights, the critical care pulmonologist arrives home weary in the early dawn.

View More

Show All +

Social

Articles

Incidence, risk factors, and sequelae of dysphagia mediated aspiration following lung transplantation

The Journal of Heart and Lung Transplantation

Justine Dallal-York, et. al

2022-05-26

We aimed to determine dysphagia profiles before and after lung transplantation (prevalence, incidence) and to examine predictors and health-related outcomes of aspiration in individuals undergoing lung transplantation. A retrospective single-center study of consecutive adults undergoing lung transplantation and completing a postoperative videofluoroscopic swallowing study between 2017 and 2020 was conducted.

View more

Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries

The Lancet Respiratory Medicine

Ankit Bharat, et. al

2021-04-27

Lung transplantation is a life-saving treatment for patients with end-stage lung disease; however, it is infrequently considered for patients with acute respiratory distress syndrome (ARDS) attributable to infectious causes. We aimed to describe the course of disease and early post-transplantation outcomes in critically ill patients with COVID-19 who failed to show lung recovery despite optimal medical management and were deemed to be at imminent risk of dying due to pulmonary complications.

View more

Intravenous Alpha-1 Antitrypsin Therapy for Alpha-1 Antitrypsin Deficiency: The Current State of the Evidence

Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation

Mark L. Brantly, et. al

2018-11-28

Alpha-1 antitrypsin deficiency (AATD) is a largely monogenetic disorder associated with a high risk for the development of chronic obstructive pulmonary disease (COPD) and cirrhosis. Intravenous alpha-1 antitrypsin (AAT) therapy has been available for the treatment of individuals with AATD and COPD since the late 1980s. Initial Food and Drug Administration (FDA) approval was granted based on biochemical efficacy.

View more

Media